Overview

A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Children 0-24 months of age requiring a urethral catheterization for urine collection will be randomized to receive either topical and intraurethral 2% lidocaine or standard of care to assess for the effectiveness of the former in minimizing pain during urethral catheterization. It is hypothesized that administration of 2% lidocaine gel both topically and intraurethrally will confer a greater degree of pain reduction compared to standard of care.
Phase:
Phase 2
Details
Lead Sponsor:
Lawson Health Research Institute
Treatments:
Lidocaine